Early BioNTech, Pfizer data suggests boosters may protect against Omicron infection

The content originally appeared on: Cayman Compass

BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test, an early signal that booster shots could be key to protection against infection from the newly identified variant.